The global demand for endoscope reprocessing devices is estimated to reach USD 3.1 Billion by 2032. A number of factors contribute to the overall growth of the economy, including:
| Attributes | Key Statistics |
|---|---|
| Global Endoscope Reprocessing Device Market Estimated Size (2022E) | USD 1.4 Billion |
| Projected Market Valuation (2032F) | USD 3.1 Billion |
| Value-based CAGR (2022 to 2032) | 7.8% |
| Collective Value Share: Top 5 Countries | 53.1% |
Endoscopes of all kinds require high-level disinfection, which is the driving force behind the development of an automated endoscope reprocessing device. Advanced endoscope reprocessing has gained attention across the healthcare industry for reasons related to endoscope functionality and its proper maintenance. According to a 2014 study, facilities with automated endoscope reprocessing increased productivity compared to those with manual reprocessing, particularly when manual soak time exceeded normal procedure times.
The current state of the science regarding endoscope reprocessing is not clear, and several issues remain unresolved. To confirm standard practices, additional research is needed, including an evaluation of the best ways to store endoscopes, the proper frequency of replacing accessories such as water bottles and connecting tubes, as well as the testing of endoscopes after reprocessing for microbiological surveillance.
For instance, high level disinfectants or liquid chemical sterilants are used in AERs to kill microorganisms on or inside reusable endoscopes. Premarket notification [510(k)] processes are used to clear AER devices as Class II devices for sales. Developing reprocessing instructions with industry, specifically manufacturers of AERs that reprocess duodenoscopes, to improve the safety margin of the processes used to clean and disinfect endoscopes.
Reprocessing duodenoscopes within a margin of safety is a priority for the FDA as it works with AER manufacturers. During periodic updates of the table, the FDA will inform the public when sufficient updated validation results have been published for other AERs currently on the market. In order to facilitate or eliminate the need for reprocessing, the FDA advises hospitals, endoscopy centers, and manufacturers to migrate away from older models with fixed endcaps, and to the newer ones with more modern design features. For information regarding validation testing for the new duodenoscope designs, facilities should contact the AER manufacturer.
Certain policies are necessary to define how long an endoscope can be used after being reprocessed before it needs to be re-disinfected, according to the European Society of Gastrointestinal Endoscopy (ESGE) and the European Society of Gastroenterology Nurses and Associates (ESGNA). Reprocessing endoscopes must be completed within 12 to 72 hours, according to Australian guidelines. Limited studies have prevented the Society of Gastroenterology Nursing and Associates from making any recommendations regarding storage intervals.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Water bottles and air insufflation tubes used in endoscopy, lens wash water used for the cleaning of lenses, and waste vacuum canisters for use in waste vacuums are all items that have limited research evidence to support their replacement at the proper intervals.
Lack of sterilization, inadequate cleaning, or the use of tap water instead of sterile water have all contributed to the transmission of infections involving water bottles and connecting tubes. The automated cleaning, disinfection, and sterilization of endoscopes, as well as reminders to clinicians, is becoming an increasingly critical aspect of maintaining optimal infection control.
There are several new products that are being developed and are being tested before they are released on the market in order to ensure their quality.
Various types of endoscopes reprocessing devices such as automated endoscope reprocessors, washer disinfectors, ultrasonic washers, and sterilizers are used for the cleaning of medical devices and for decontamination purposes. An automated endoscope reprocessor has a unique capability to target hard-to-reach areas of the endoscope, as compared to other conventional procedures. Automated endoscope reprocessors have overall cleaning features in one machine.
Endoscopes are flexible or rigid tubes attached with various miniature tools such as a camera, a light source, forceps, and vacuum pump to examine and diagnose. These are set to be extensively used for biopsy purposes, which may boost the demand for endoscopes and drive the market.
In contrast to conventional surgical operations, endoscopic techniques require only a small incision or body opening, which reduces the risk of infection. The cost of healthcare is greatly reduced by the use of endoscopes. Endoscopic operations are quick and require a shorter hospital stay, thereby reducing the risk of complications.
The global endoscope reprocessing device market held approximately 43.4% of the global medical device reprocessing market, which was worth USD 3.1 Billion in 2021. Sales of endoscope reprocessing devices expanded at a CAGR of 6.5% from 2012 to 2021 due to the increasing prevalence of chronic disorders.
Increasing demand for minimally invasive procedures, also known as endoscopic procedures, will have a positive impact during the forecast period. This can be attributed to the rising incidence rate of diseases and growing aging population, which adds to the pool of customer base.
In addition, various original equipment manufacturers and third-party service vendors are focusing on collaboration and partnership activities with local players from emerging regions to provide sales and after-sales services effectively in these regions.
These collaboration and partnership activities would also boost the brand image of endoscope reprocessing devices manufacturers, which is expected to fuel growth in the global endoscope reprocessing device market. Thus, owing to these factors, the global endoscope reprocessing device market is expected to grow at a CAGR of 7.8% during the forecast period.
Principal Consultant
Burgeoning Demand for Non-Disposable Medical Instruments
Emerging economies such as India, China, Brazil, Mexico, and South Africa have a large number of under-served patients. These countries would provide various growth opportunities to players operating in the medical device market. Growth in patients’ disposable income and rapid economic development in these emerging markets will also help to secure the market's viability.
Improvements in healthcare policies in countries like the USA, Japan, the UK, and China have led to the increasing cost-effectiveness of various treatment services. As a result, the population's life expectancy has grown. The majority of ailments that affect elderly individuals (including infections, blood pressure issues, and CVDs) require diagnosis and treatment.
The use of several non-disposable medical instruments such as syringes, tubes, and scissors, is required for both diagnosis and therapy. To prepare them for use on more patients, these tools are frequently cleaned and disinfected. As a result, the usage of disinfectants would rise with the increasing number of aging people across the globe.
This factor would further push the demand for endoscope reprocessing devices as these are capable of disinfecting medical devices efficiently. Likewise, rising healthcare expenditure would encourage endoscope reprocessing device manufacturers to enter the market in the next decade.
As compared to conventional procedures (manual cleaning procedure), endoscope reprocessing devices such as automated endoscope devices are expensive. This may indirectly affect the decontamination and disinfection of endoscope devices. Thus, high cost of initial set-up and installation may hamper the demand for endoscope reprocessing devices and further restrain growth in the endoscope reprocessing device market over the forecast period.
Furthermore, due to the lack of health insurance and constrained government support programs for endoscopic therapy in developing nations like India and China, the price of endoscopy operations is a significant issue for a large population. One of the main factors limiting the endoscope industry is the lack of social health insurance and the restrictive nature of private health insurance plans. All the aforementioned factors are thus expected to restrain the market over the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
High Prevalence of Colorectal Cancer in the USA to Drive Sales of Endoscope Sterilization Machines
In 2021, the USA held the maximum share of about 89.0% in the North America endoscope reprocessing device market. The prevalence of gastrointestinal diseases and colorectal diseases in the country is anticipated to boost the demand for endoscopy procedures and further propel growth in the endoscope reprocessing devices market in the USA Colorectal cancer is one of the most frequent diseases in the country.
According to the statistics by Globocan, the prevalence was 6.8% in 2020 in the USA Moreover, increasing number of other chronic diseases such as gastrointestinal bleeding, stomach cancer, and functional gastrointestinal diseases is expected to push the demand for endoscopy procedures, which will propel the need for endoscope reprocessors.
Rising Cases of Bacterial Infection to Boost the Need for Endoscope Reprocessing Manuals in Japan
Japan held approximately 7.7% of share in the global endoscope reprocessing device market in 2021, and is projected to witness growth at a CAGR of 6.8% during the forecast period. Endoscopes that have been improperly reprocessed are the cause of bacterial infection outbreaks linked to their use.
The market for endoscope reprocessing devices in Japan is anticipated to rise as technicians and doctors are becoming increasingly concerned about patient safety. Flexible endoscopy is linked to growing knowledge about the use of endoscope reprocessing for the prevention of external and endogenous infections, which is anticipated to drive the demand for endoscope reprocessor systems in Japan.
Availability of Affordable Endoscope Reprocessing Medical Supplies in India to Aid Growth
India accounted for a share of around 5.5% in 2021 in the global endoscope reprocessing device market. Due to several advantages, including faster procedure times, shorter hospital stays, effectiveness, and assurance of contamination-free procedures, automated endoscope reprocessing is becoming more popular in the country, as compared to conventional techniques.
The need for endoscopes in India is mainly being driven by increasing popularity of minimally invasive surgical procedures that are related to endoscopy. Easy availability of endoscopes is also facilitated by their rising affordability. In light of the increasing need for endoscopes in the country, the market in India is anticipated to be the most lucrative for endoscope reprocessing devices.
Sterilizer Medical Equipment to Gain Immense Popularity by 2032
Based on product, the global endoscope reprocessing device market is segmented into automated endoscope reprocessor, washer disinfector, sterilizer, ultrasonic washer, and drying & storage cabinet. Amongst these, the sterilizer segment is expected to dominate the global market and it held a share of around 32.8% in 2021. With the rising number of surgeries worldwide, the use of sterilizers has also increased. Compared to other products, sterilizers are less expensive and can kill the majority of the resistant bacterial spores, thereby driving the market.
Disinfectants for Endoscopes Are to Be Extensively Utilized in Hospitals
Hospitals held a market share of around 68.8% in 2021 and the segment is expected to grow at a CAGR of 8.2% in the projected period. The majority of surgical procedures are carried out in hospitals. Hence, these are more prone to cross-contamination and the spread of infections.
To prevent chronic infections, hospitals make use of sterilizers, automated endoscope reprocessors, and other advanced devices on a large scale. Therefore, hospitals are a major contributor in the endoscope reprocessing device market.
To meet the high demand from various end users and expand their businesses, key players operating in the endoscope reprocessing device market are launching new products with improved technologies and are also opening advanced production centers. Apart from that, some of these manufacturers are signing distribution agreements and acquiring local companies to reach a larger consumer base.
A few strategies undertaken by key players in the endoscope reprocessing device market are:
| Attribute | Details |
|---|---|
| Estimated Market Size (2022) | USD 1.4 Billion |
| Projected Market Valuation (2032) | USD 3.1 Billion |
| Value-based CAGR (2022 to 2032) | 7.8% |
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2012 to 2021 |
| Market Analysis | Value (USD Billion) |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, and South Africa |
| Key Market Segments Covered | Product, End User, and Region |
| Key Companies Profiled | Medivators Inc; Olympus Corporation; STERIS; Getinge AB; HOYA Corporation; Laboratories Anios; customultrasonics.com; SciCan Inc; SHINVA MEDICAL INSTRUMENT CO., LTD; ARC Group of Companies Inc.; MATACHANA; Choyang Medical Industry Ltd; DGM Infection Control Systems; MMM Medical Equipment UK LTD; Medonica Co. LTD; Belimed AG (Metall Zug); Steelco S.P.A; Advanced Sterilization Products Services Inc. |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
The global endoscope reprocessing device market was worth USD 1.3 Billion in 2021.
The endoscope reprocessing device market is expected to reach USD 3.1 Billion by the end of 2032, with sales revenue likely to register a 7.8% CAGR from 2022 to 2032.
Rising technological advancements, higher spending on healthcare facilities, increasing prevalence of infections, rising rate of disease transmission, and growing demand for automated reprocessing over manual cleaning procedures are some of the key trends shaping the endoscope reprocessing device market.
The USA, China, Japan, India, and Germany are the top five countries driving the demand for endoscope reprocessing devices.
The North America endoscope reprocessing device market registered a share of around 30.2% in 2021.
The Middle East and Africa (MEA) endoscope reprocessing device market is expected to register a CAGR of 7.1% during the forecast period.
The USA, Japan, and China are the key producers of endoscope reprocessing devices.
The Japan endoscope reprocessing device market was worth more than USD 100 Million in 2021.
The UK endoscope reprocessing device market created an incremental opportunity of around USD 62.9 Million in 2021.
Olympus Corporation, STERIS, Getinge AB, HOYA Corporation, SciCan Inc, SHINVA MEDICAL INSTRUMENT CO., LTD, Belimed AG (Metall Zug) and Steelco S.P.A, and Advanced Sterilization Products Services Inc. are the key players in the endoscope reprocessing device market.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Key Success Factors 5. Market Background 6. Global Endoscope Reprocessing Device Market Volume Analysis 2012 to 2021 and Forecast, 2022 to 2032 7. Global Endoscope Reprocessing Device Market - Pricing Analysis 8. Global Endoscope Reprocessing Device Market Demand (in Value or Size in USD Billion) Analysis 2012 to 2021 and Forecast, 2022 to 2032 9. Global Endoscope Reprocessing Device Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product 9.1. Automated Endoscope Reprocessor 9.1.1. Single Basin AER 9.1.2. Dual Basin AER 9.2. Washer Disinfector 9.2.1. Single Chamber 9.2.2. Multiple Chamber 9.3. Sterilizer 9.4. Ultrasonic Washer 9.5. Drying and Storage Cabinet 9.5.1. Single Door 9.5.2. Double Door 10. Global Endoscope Reprocessing Device Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User 10.1. Hospitals 10.2. Ambulatory Surgical Centers 10.3. Specialty Clinics 11. Global Endoscope Reprocessing Device Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Region 11.1. North America 11.2. Latin America 11.3. Europe 11.4. South Asia 11.5. East Asia 11.6. Oceania 11.7. Middle East & Africa 12. North America Endoscope Reprocessing Device Market Analysis 2012 to 2021 and Forecast 2022 to 2032 13. Latin America Endoscope Reprocessing Device Market Analysis 2012 to 2021 and Forecast 2022 to 2032 14. Europe Endoscope Reprocessing Device Market Analysis 2012 to 2021 and Forecast 2022 to 2032 15. South Asia Endoscope Reprocessing Device Market Analysis 2012 to 2021 and Forecast 2022 to 2032 16. East Asia Endoscope Reprocessing Device Market Analysis 2012 to 2021 and Forecast 2022 to 2032 17. Oceania Endoscope Reprocessing Device Market Analysis 2012 to 2021 and Forecast 2022 to 2032 18. Middle East and Africa Endoscope Reprocessing Device Market Analysis 2012 to 2021 and Forecast 2022 to 2032 19. Market Structure Analysis 20. Competition Analysis 20.1. Olympus Corporation 20.2. STERIS 20.3. Getinge AB 20.4. HOYA Corporation 20.5. Laboratoires Anios 20.6. customultrasonics.com 20.7. SciCan Inc 20.8. SHINVA MEDICAL INSTRUMENT CO., LTD 20.9. ARC Group of Companies Inc. 20.10. MATACHANA 20.11. Choyang Medical Industry Ltd 20.12. DGM Infection Control Systems 20.13. MMM Medical Equipment UK LTD 20.14. Medonica Co. LTD 20.15. Belimed AG (Metall Zug) 20.16. Steelco S.P.A 20.17. Advanced Sterilization Products Services Inc. 20.18. Medivators Inc. 21. Assumptions and Acronyms Used 22. Research Methodology
Explore Healthcare Insights
View Reports
Endoscope Reprocessing Device Market
